# Factors Affecting Post-treatment Outcomes in Patients With Hepatocellular Carcinoma

> **NCT04553458** · — · COMPLETED · sponsor: **Sohag University** · enrollment: 407 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **DEVICE:** Radiofrequency ablation
- **DRUG:** Trance-arterial chemoembolization
- **PROCEDURE:** Liver resection
- **COMBINATION_PRODUCT:** Combined radiofrequency ablation + percutaneous ethanol injection
- **DRUG:** Percutaneous ethanol injection
- **DRUG:** Systemic chemotherapy
- **DRUG:** Sorafenib
- **DIETARY_SUPPLEMENT:** Viscum
- **DRUG:** Symptomatic treatment

## Key facts

- **NCT ID:** NCT04553458
- **Lead sponsor:** Sohag University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2020-06
- **Final completion:** 2020-06
- **Target enrollment:** 407 (ACTUAL)
- **Last updated:** 2020-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04553458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04553458, "Factors Affecting Post-treatment Outcomes in Patients With Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04553458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*